1337 Ventures has announced the launch of Alpha Startups Inno4Her, Southeast Asia’s first femtech-focused accelerator program. The eight-week program aims to help startups validate ideas, achieve product-market fit, and scale their businesses in the women’s health sector. “Femtech is still nascent in Southeast Asia, but we see its immense potential to transform women’s healthcare,” said Bikesh Lakhmichand, CEO and founding partner of…
Ovesse, a vaginal oestrogen cream, has become the first of its kind available over-the-counter in the UK offering new possibilities for millions of postmenopausal women suffering from vaginal atrophy, a condition affecting approximately 50% of women after menopause. Ovesse is a prescription-strength vaginal cream containing estriol, a naturally occurring oestrogen hormone. It’s designed to treat vaginal atrophy by replacing the oestrogen no…
Evernow has announced a partnership with Clearblue to provide users of the Clearblue Menopause Stage Indicator access to specialized menopause healthcare. The collaboration aims to reach up to 35 million women in menopause transition, offering them a path from at-home testing to professional care. Users of Clearblue’s Menopause Stage Indicator, launched in August 2023, will be eligible for a one-month free care…
Bayer has announced that elinzanetant met all primary and secondary endpoints in its Phase III OASIS 4 study for treating moderate to severe vasomotor symptoms (hot flashes) caused by breast cancer treatments. The trial focused on women with or at high risk of developing hormone receptor-positive breast cancer who experience hot flashes due to adjuvant endocrine therapy. The study demonstrated statistically significant…
Hippocratic AI has launched its Healthcare AI Agent App Store, a platform enabling clinicians to create AI solutions for patient care across multiple specialties. The platform’s founding clinicians have already developed over 300 AI agents covering more than 25 medical specialties. The founding contributors include specialists across various healthcare fields. Among them, Dr. Vanessa Dorismond focuses on cervical cancer check-ins, Kristina Dulaney…
ScreenPoint Medical has announced the acquisition of Biomediq A/S, a research company specializing in quantitative imaging biomarkers. The acquisition follows a decade of collaboration between the companies on image-based risk assessment and aims to integrate breast cancer risk assessment capabilities into ScreenPoint’s Transpara Breast AI platform. Biomediq’s technology enables automatic computer-based analysis of 2D and 3D mammograms for future breast cancer risk…
Highlights Reproductive health startup Twentyeight Health raises $10M Series A; expands Medicaid partnership. Preventative health platform Superpower acquires Feminade to strengthen its women’s health offering. Medtech company Hologic acquires Gynesonics for $350M. Celmatix launches novel endometriosis program. WHOOP unveils a novel digital biomarker for menstrual cycle monitoring in Nature study. Femtech pioneer Elvie launches a smart bouncer-bassinet combo for safer infant sleep. Elyfia launches a digital health coaching platform for fibromyalgia patients. “Dare to Invest in Women’s Health”: Daré Bioscience and ARPA-H rang Nasdaq Closing…
Celmatix announced a new drug development program targeting endometriosis through a novel Jun-N-terminal kinase (JNK) inhibitor. The therapeutic candidate, developed using Baylor College of Medicine‘s DNA-Encoded Chemistry Technology platform, aims to address pain and inflammation associated with endometriosis. The program targets a significant medical need, as endometriosis affects over 10% of girls and women aged 15-45 worldwide. In the US, the condition…
